Gain Therapeutics Inc Earnings

The next earnings date for Gain Therapeutics Inc has not yet been scheduled.

Analyst Estimates of Gain Therapeutics Inc Earnings

No Results.
Report DateEstimated Earnings Per Share
No Results.

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Gain Therapeutics Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
11/07/2025---$0100.00%
08/08/2025---$0100.00%
05/12/2025Before Market$-0.1611.11%
03/24/2025Before Market------
11/12/2024Before Market$-0.1719.05%
08/08/2024Before Market$-0.42-110.00%
05/14/2024Before Market$-0.2224.14%
03/26/2024Before Market$-0.36-12.50%
11/14/2023Before Market$-0.3717.78%
08/10/2023Before Market$-0.62-100.00%
05/12/2023Before Market$-0.43-10.26%
03/23/2023After Market$-0.39-2.63%
11/10/2022After Market$-0.3817.39%
08/08/2022Before Market$-0.43-38.71%
05/16/2022After Market$-0.2824.32%
03/24/2022Before Market$-0.3234.69%
11/12/2021Before Market$-0.39-8.33%
08/11/2021After Market$-0.300.00%
05/10/2021After Market$-0.50-138.10%
03/22/2021After Market$0---
12/31/2020---$-0.41---
12/31/2019---$-0.32---

More About Gain Therapeutics Inc

Country
USA
Full Time Employees
23

Gain Therapeutics, Inc., a biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas in Switzerland, Spain, the United States, and Australia. Its drug discovery platform Magellan discovers novel allosteric binding sites in a disease; identifies proprietary small molecules that bind these sites to modulate protein function; and treats the underlying cause of the disease. The company's lead drug candidate is GT-02287, which is currently in a Phase 1b study for the treatment of Parkinson's disease with or without a GBA1 mutation. It has various small molecule drug candidates, which are in the discovery, research, and preclinical stages for the treatment of dementia with Lewy bodies, Alzheimer's disease, and Gaucher's disease, lysosomal storage disorders, metabolic disorders, and solid tumors. Gain Therapeutics, Inc. was founded in 2017 and is based in Bethesda, Maryland.

Gain Therapeutics Inc Earnings” Can Refer to the Gain Therapeutics Inc Earnings Date

Some people say “Gain Therapeutics Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Gain Therapeutics Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Gain Therapeutics Inc Stock on the Earnings Date

If you own Gain Therapeutics Inc stock (GANX) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Gain Therapeutics Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Gain Therapeutics Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Gain Therapeutics Inc Earnings

You can contact us any time if you would like to ask questions about Gain Therapeutics Inc earnings or anything else related to the stock market.